Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
托法替尼剂量递增治疗难治性抗MDA5抗体阳性皮肌炎的疗效和安全性
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2022-002795
Ida, Tomoaki; Furuta, Shunsuke; Takayama, Asuka; Tamura, Jun; Hayashi, Yuki; Abe, Kazuya; Kurihara, Syunjiro; Ishikawa, Junichi; Iwamoto, Taro; Ikeda, Kei; Suzuki, Kotaro; Nakajima, Hiroshi
